IGF2BP2 and dilated cardiomyopathy: Furthermore, activating IGF2BP2 expression in either newborn or adult transgenic mice results in dilated cardiomyopathy leading to heart failure or cardiac dysfunction and precocious death within 3–4 weeks after induction of expression.